UiPath, Inc. (PATH) vs. Anika Therapeutics, Inc. (ANIK) Stock Comparison & Valuation

Quick read

Fair value engine

Each company valued on the other's multiple, then compared with the market price.

PATH · current priceP/S 4.94x

$15.20Latest market snapshot

Implied fair value · at ANIK's multiple

$7.4051.3% below market

2.99 PATH revenue / share×2.47x ANIK P/S=$7.40

Market $15.20Implied $7.40

ANIK · current priceP/S 2.47x

$20.83Latest market snapshot

Implied fair value · at PATH's multiple

$41.66100.0% above market

8.43 ANIK revenue / share×4.94x PATH P/S=$41.66

Market $20.83Implied $41.66